Our Services
Medical Information
Helpful Resources
Published on: 9/26/2026
Zetia (ezetimibe) is a non-statin prescription medication that blocks cholesterol absorption in the small intestine, and it is used to lower LDL "bad" cholesterol in people with high cholesterol, familial hypercholesterolemia, or sitosterolemia, either alone or alongside a statin. Used by itself, it typically reduces LDL cholesterol by roughly 15% to 20%, and when added to a statin it can lower LDL by an additional 20% to 25% on average. Your actual results depend on several factors, including your dose, diet, genetics, other medications, and whether you have heart or liver disease, and there are important side effects and drug interactions to weigh. See below to understand the full picture before assuming Zetia is or is not the right fit for your numbers.
If your cholesterol concerns come with symptoms like chest discomfort, unusual fatigue, muscle aches, leg pain when walking, or shortness of breath, those clues matter and should not be guessed at, because high cholesterol itself is silent while its complications are not. Take a free, instant, online symptom check to see which conditions may explain what you are feeling and get clear guidance on your next steps.
Last reviewed for medical accuracy: 09/26/2026
Zetia (generic name: ezetimibe) is a prescription medication used alongside diet and lifestyle changes to help lower elevated cholesterol levels. It belongs to a class of drugs that reduces the amount of cholesterol absorbed by your small intestine, leading to lower levels of “bad” LDL cholesterol in your bloodstream.
Zetia targets the Niemann-Pick C1-like 1 (NPC1L1) protein in the lining of your small intestine. By blocking this protein, Zetia reduces the absorption of dietary and biliary cholesterol. With less cholesterol entering your bloodstream, your liver pulls more LDL cholesterol out of circulation, which helps lower overall LDL levels.
Zetia is approved by the U.S. Food and Drug Administration (FDA) for:
Clinical trials and real-world studies show:
Individual response varies based on factors such as baseline cholesterol levels, diet, exercise, and genetics.
Your healthcare provider may consider Zetia if:
Most people tolerate Zetia well. Common side effects (occurring in 1–10% of patients) include:
Rare but serious side effects may include:
Always inform your doctor if you notice anything unusual or bothersome.
To ensure Zetia is working safely and effectively, your doctor will likely:
Zetia addresses one piece of cardiovascular risk. For the best long-term outcomes, also focus on:
You might consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker to review any new concerns or side effects as you start Zetia.
If you’re concerned about high cholesterol or side effects from your current therapy:
Never stop or change your medication without talking to your healthcare provider—especially for anything that could be life threatening or serious.
(References)
* Meng CQ. Ezetimibe (Schering-Plough). Curr Opin Investig Drugs. 2001 Mar;2(3):389-92. PMID: 11575710.
* Bays H. Ezetimibe. Expert Opin Investig Drugs. 2002 Nov;11(11):1587-604. doi: 10.1517/13543784.11.11.1587. PMID: 12437505.
* Darkes MJ, Poole RM, Goa KL. Ezetimibe. Am J Cardiovasc Drugs. 2003;3(1):67-76; discussion 77-8. doi: 10.2165/00129784-200303010-00007. PMID: 14727947.
* Ballantyne CM, Banach M, Mancini GBJ, Lepor NE, Hanselman JC, Zhao X, Leiter LA. Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study. Atherosclerosis. 2018 Oct;277:195-203. doi: 10.1016/j.atherosclerosis.2018.06.002. Epub 2018 Jun 12. PMID: 29910030.
* Ballantyne CM, Laufs U, Ray KK, Leiter LA, Bays HE, Goldberg AC, Stroes ES, MacDougall D, Zhao X, Catapano AL. Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy. Eur J Prev Cardiol. 2020 Apr;27(6):593-603. doi: 10.1177/2047487319864671. Epub 2019 Jul 29. PMID: 31357887; PMCID: PMC7153222.
* Burnett H, Fahrbach K, Cichewicz A, Jindal R, Tarpey J, Durand A, Di Domenico M, Reichelt A, Viljoen A. Comparative efficacy of non-statin lipid-lowering therapies in patients with hypercholesterolemia at increased cardiovascular risk: a network meta-analysis. Curr Med Res Opin. 2022 May;38(5):777-784. doi: 10.1080/03007995.2022.2049164. Epub 2022 Mar 20. PMID: 35262430.
* Sinning D, Landmesser U. [Hypercholesterolemia and cardiovascular risk]. Dtsch Med Wochenschr. 2023 Aug;148(16):1025-1032. doi: 10.1055/a-1932-6448. Epub 2023 Aug 4. PMID: 37541292.
* Ki YJ, Kim W, Lee KH, Han SJ, Kim YH, Doh JH, Kim TN, Chung CH, Kim DY, Cho JM, Yoon HJ, Jeong IK, Park S, Song KH, Yu CW, Cho DK, Choi SH, Oh SJ, Shin S, Jeong H, Park Y, Kim HS. Lipid-Lowering Effect and Safety of Ezetimibe and Atorvastatin 5 mg in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia: A Randomized, Double-Blind, Parallel, Multicenter, Phase 3 Clinical Trial. Clin Cardiol. 2025 May;48(5):e70138. doi: 10.1002/clc.70138. PMID: 40357888; PMCID: PMC12070249.
* Hong SJ, Kim JH, Cha KS, Lee JB, Moon JY, Cho GY, Cho DK, Park JP, Yi JE, Kim KH, Jeong H, Rhee MY, Lee JH, Ahn KT, Yoon YW, Lee SY, Sung KC, Cha TJ, Shin J, Cho YH, Son JW, Ahn JH, Park SD, Kang WC, Hahn JY, Ha JW. Efficacy and Safety of Fimasartan, Atorvastatin, and Ezetimibe Combination Therapy in Patients With Hypertension and Dyslipidemia: A Randomized, Double-Blind, Multicenter, Therapeutic Confirmatory, Phase III Clinical Trial. Clin Ther. 2025 Nov;47(11):1028-1036. doi: 10.1016/j.clinthera.2025.08.012. Epub 2025 Sep 14. PMID: 40947318.
* Alidema F, Alidema A, Mustafa L, Havolli M, Abazi F. LDL-CHOLESTEROL LOWERING WITH ATORVASTATIN, ROSUVASTATIN AND SIMVASTATIN: RESULTS OF A RETROSPECTIVE OBSERVATIONAL STUDY. Georgian Med News. 2025 Dec;(369):204-209. PMID: 41687656.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.